Many studies have indicated that transcutaneous allergic sensitization may be facilitated by FLG null-mutations, and that both peanut allergy and AD are strongly associated with FLG loss-of-function variants [9,10,11,12], as well as other cutaneous conditions [13,14]. This evidence concerns the gene FLG and Alzheimer disease.